Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
Clinical trial NCT01657591 · COMPLETED
Trial details
- NCT number
- NCT01657591
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-27
- Primary completion
- 2016-09-20
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.